abstract |
Provided is a transgenic T cell. A genome of the transgenic T cell stably integrates an expression cassette of a nucleic acid sequence comprising a code chimeric antigen receptor, an immune co-stimulatory molecule or an activated antibody of a receptor thereof, and an inverted terminal repeat, two ends of which comprise transposons. Also provided are a pharmaceutical composition comprising the transgenic T cell, and a nucleic acid construct. |